Literature DB >> 5029040

D-tubocurarine dosage based on lean body mass.

N L Wulfsohn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5029040     DOI: 10.1007/BF03028291

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


× No keyword cloud information.
  45 in total

1.  KINETICS OF DISTRIBUTION OF RADIOACTIVE-LABELED MUSCLE RELAXANTS. 1. INVESTIGATIONS WITH C14-DIMETHYL-D-TUBOCURARINE.

Authors:  G DALSANTO
Journal:  Anesthesiology       Date:  1964 Nov-Dec       Impact factor: 7.892

2.  The influence of changes in blood pH on the neuromuscular blocking properties of tubocurarine and dimethyl tubocurarine in the cat.

Authors:  J P PAYNE
Journal:  Acta Anaesthesiol Scand       Date:  1960       Impact factor: 2.105

3.  The role of the canine liver in the detoxication of d-tubocurarine chloride, gallamine triethiodide and laudexium.

Authors:  A L STEAD; W H H ANDREWS
Journal:  Br J Anaesth       Date:  1957-04       Impact factor: 9.166

4.  Pharmacological studies of d-tubocurarine and other curare fractions.

Authors:  G M EVERETT
Journal:  J Pharmacol Exp Ther       Date:  1948-03       Impact factor: 4.030

5.  The distribution, metabolism, and excretion of d-tubocurarine chloride and related compounds in man and other animals.

Authors:  D F MARSH
Journal:  J Pharmacol Exp Ther       Date:  1952-07       Impact factor: 4.030

6.  Controlled relaxation. II. Clinical management of muscle-relaxant administration.

Authors:  R H De Jong
Journal:  JAMA       Date:  1966-12-12       Impact factor: 56.272

7.  Response to tubocurarine chloride and its reversal by neostigmine methylsulfate in man.

Authors:  P O Bridenbaugh; H C Churchll-Davidson
Journal:  JAMA       Date:  1968-02-19       Impact factor: 56.272

8.  Durations of action of d-tubocurarine and gallamine.

Authors:  L F Walts; J B Dillon
Journal:  Anesthesiology       Date:  1968 May-Jun       Impact factor: 7.892

9.  The muscle relaxants and renal excretion.

Authors:  H C Churchill-Davidson; W L Way; R H De Jong
Journal:  Anesthesiology       Date:  1967 May-Jun       Impact factor: 7.892

10.  The effct of d-tubocurarine on respiratory resistance in anesthetized man.

Authors:  H U Gerbershagen; N A Bergman
Journal:  Anesthesiology       Date:  1967 Nov-Dec       Impact factor: 7.892

View more
  3 in total

1.  Clinical pharmacokinetics of muscle relaxants.

Authors:  L B Wingard; D R Cook
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

2.  Clinical comparison of D-tubocurarine and pancuronium: dosage schedule based on lean body mass.

Authors:  E Nickorick; F B Reynolds
Journal:  Can Anaesth Soc J       Date:  1973-03

Review 3.  Lean body mass as a predictor of drug dosage. Implications for drug therapy.

Authors:  D J Morgan; K M Bray
Journal:  Clin Pharmacokinet       Date:  1994-04       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.